Skip to content
← Back to this collection

PUBLICATIONS · 17910629

Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Haematol
Publication date
2007 Nov
First author
Maddocks-Christianson K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Maddocks-Christianson K
      type
      Author
    2. name
      Slager SL
      type
      Author
    3. name
      Zent CS
      type
      Author
    4. name
      Reinalda M
      type
      Author
    5. name
      Call TG
      type
      Author
    6. name
      Habermann TM
      type
      Author
    7. name
      Bowen DA
      type
      Author
    8. name
      Hoyer JD
      type
      Author
    9. name
      Schwager S
      type
      Author
    10. name
      Jelinek DF
      type
      Author
    11. name
      Kay NE
      type
      Author
    12. name
      Shanafelt TD
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Maddocks-Christianson K
      type
      Author
    2. name
      Slager SL
      type
      Author
    3. name
      Zent CS
      type
      Author
    4. name
      Reinalda M
      type
      Author
    5. name
      Call TG
      type
      Author
    6. name
      Habermann TM
      type
      Author
    7. name
      Bowen DA
      type
      Author
    8. name
      Hoyer JD
      type
      Author
    9. name
      Schwager S
      type
      Author
    10. name
      Jelinek DF
      type
      Author
    11. name
      Kay NE
      type
      Author
    12. name
      Shanafelt TD
      type
      Author
    bibliography ids
    1. nci-bib-d6997e664f243791feacd783
    book metadata
    content sha256
    3a2b548372cb0d4f509bee634aa4fe30fdb7e6f9cb96962d4ecb3aa867c7b539
    document type
    citation
    dois
    1. 10.1111/j.1365-2141.2007.06801.x
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:17910629
    immutable id
    pubmed:17910629@3a2b548372cb0d4f509bee634aa4fe30fdb7e6f9cb96962d4ecb3aa867c7b539
    journal
    abbreviation
    Br J Haematol
    issn electronic
    Source null
    issn print
    0007-1048
    issue
    3
    name
    British journal of haematology
    nlm unique id
    0372544
    pages
    398-404
    volume
    139
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      17910629
      provenance
      batch id
      89a0f2206e11ca092d02
      provider
      NCBI PubMed ESummary
      record sha256
      06c55f0ab3986fcc760a81d283d6158802f1b9d9bf2c67e7670509524493c141
      response sha256
      7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
      retrieved at
      2026-09-09T23:46:16.784581+00:00
      publication date
      display
      2007 Nov
      precision
      month
      year
      2007
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/17910629/
      title
      Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.

      Preserved source evidence · Not medical advice